Evidence for induction of interferon-α and interferon-β in retinal glial cells of Muller

Virology

Volumn 234, Issue 2, 1997, Pages 309-316

  Drescher, Kristen M ^a   Whittum Hudson, Judith A ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERFERON; MESSENGER RNA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; GENETIC TRANSCRIPTION; GLIA CELL; HERPES SIMPLEX VIRUS 1; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFECTION RESISTANCE; MOUSE; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; RETINA CELL; RETINITIS; RNA ANALYSIS; VIRUS INFECTION;

ANIMALIA; GILA; HERPES; HUMAN HERPESVIRUS 1; MURINAE;

EID: 0030799535     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8661     Document Type: Article

References (46)

1. Allen J. E., Shellam G. R. Characterization of interferon induction in mice of resistant and susceptible strains during cytomegalovirus infection. J. Gen. Virol. 66:1985;1105-1112.
2. Atherton S. S., Streilein J. W. Two waves of virus following anterior chamber inoculation of HSV-1. Invest. Ophthal. Vis. Sci. 28:1987;571-579.
3. Barnhart D. C., Mayer E. P., Ghaffer A., Gangemi J. D. Cellular and humoral factors associated with polyriboinosinic-polyribocytidylic acid (poly I:C) induced resistance to Banzi virus encephalitis. Antiviral Res. 17:1992;152.
4. Belardelli F., Gresser I. The neglected role of type 1 interferon in the T-cell response: Implications for its clinical use. Immunol. Today. 17:1996;369-372.
5. Chen S., Oakes J. E., Lausch R. N. Synergistic anti-HSV effect of tumor necrosis factor-α and interferon gamma in human corneal fibroblasts is associated with interferon-β induction. Antiviral Res. 22:1993;15-29.
6. Chong K. T., Gresser I., Mims C. A. Interferon as a defense mechanism in mouse cytolomegalovirus infection. J. Gen. Virol. 64:1983;1-4.
7. Cousins S. W., Gonzalez A., Atherton S. S. Herpes simplex retinitis in the mouse: Clinicopathologic correlations. Invest. Ophthal. Vis. Sci. 30:1989;1485-1494.
8. Dhib-Jalbut S. S., Xia Q., Drew P. D., Swoveland P. T. Differential up-regulation of HLA class I molecules on neuronal and glial cell lines by virus infection correlates with differential induction of IFN-β J. Immunol. 155:1995;2096-2108.
9. Dorr R. T. Interferon-α in malignant and viral diseases. Drugs. 45:1993;177-211.
10. Drescher K. M., Whittum-Hudson J. A. Modulation of immune-associated surface markers and cytokine production by murine retinal glial cells. J. Neuroimmunol. 64:1996a;71-81.
11. Drescher K. M., Whittum-Hudson J. A. HSV-1 alters transcript levels of TNFα and IL-6 in retinal glial cells. Invest. Ophthalmol. Vis. Sci. 37:1996b;2302-2312.
12. Dulbecco R. Virology. 1988;Lippincott, Philadelphia. p. 103-115.
13. Ellermann-Eriksen S., Justesen J., Mogensen S. C. Genetically determined difference in the antiviral action of α/β-interferon in cells from mice resistant or susceptible to herpes simplex virus type 2. J. Gen. Virol. 67:1986;1859-1866.
14. Eng L. F. Glial fibrillary acidic protein (GFAP): The major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 8:1985;203-214.
15. Engler H., Zawatzky R., Kirchner H., Armerding D. Experimental infection of inbred mice with herpes simplex virus. IV. Comparison of interferon production and natural killer activity in susceptible and resistant adult mice. Arch. Virol. 74:1982;239-247.
16. Fiette L., Aubert C., Muller U., Huang S., Aguet M., Brahic M., Burgess W. H. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J. Exp. Med. 181:1995;2069-2076.
17. Gresser I., Tovey M. G., Maury C., Bandu M. Role of interferon in the pathogenesis of virus disease in mice as demonstrated by the use of anti-interferon serum. J. Exp. Med. 144:1976;1316-1323.
18. Grundy (Chalmer) J. E., Trapman J., Allan J. E., Shellam G. R., Melief C. J. M. Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H2-linked genes. Infect. Immun. 37:1982;143-150.
19. Gutterman J. U. Cytokine therapeutics: Lessons from interferon-α Proc. Natl. Acad. Sci. USA. 91:1994;1198-1205.
20. Hendricks R. L., Weber P. C., Taylor J. L., Koumbis A., Tumpey T. M., Glorioso J. C. Endogenously produced interferon-α protects mice from herpes simplex type 1 corneal disease. J. Gen. Virol. 72:1991;1601-1610.
21. Isaacs A., Lindemann J. Virus interference. I. The interferons. Proc. R. Soc. London Ser. B. 147:1957;258-267.
22. Kapoor A. K., Nash A. A., Wildy P. Pathogenesis of herpes simplex virus in B-cell suppressed mice: The relative roles of cell-mediated and humoral immunity. J. Gen. Virol. 61:1982;127-131.
23. Kunder S. C., Kelly K. M., Morahan P. S. Biological response modifier-mediated resistance to herpesvirus infections requires induction of α/β interferon. Antiviral Res. 21:1993;129-139.
24. Lausch R. N., Su Y. H., Ritchie M., Oakes J. E. Evidence for endogenous interferon production contributed to the lack of ocular virulence of an HSV intertypic recombinant. Curr. Eye Res. 10:1991;39-45.
25. LaVail M. M., Unoki K., Yasumura D., Matthes M. T., Yancopoulos G. D., Steinberg R. H. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc. Natl. Acad. Sci. USA. 89:1992;11249-11253.
26. Li H. S., Yang J. M., Jacobson R. D., Pasko D., Sundin O. Pax-6 is first expressed in a region anterior to the early neural plate: Implications for stepwise determination of the lens. Dev. Biol. 162:1994;181-194.
27. Lopez C. Genetics of natural resistance to herpesvirus infections in mice. Nature. 258:1975;152-153.
28. Manthorpe M., Pettmann B., Varon S. Modulation of astroglial cell output of neuronotropic and neurite promoting factors. Neurol. Neurobiol. 39:1988;41.
29. Merges M. J., Whittum-Hudson J. A. In vitro. Invest. Ophthal. Vis. Sci. 31:1990;1223-1230.
30. Migita K., Eguchi K., Akiguchi I., Ida H., Kawakami A., Ueki Y., Kurata A., Fukuda T., Nagataki S. Synergistic effects of phorbol ester and interferon-alpha: Target cell class I HLA antigen expression and resistance to natural killer and lymphokine-activated killer cell-mediated cytolysis. Cell. Immunol. 134:1991;325-335.
31. Morahan P. S., Pinto A. J., Stewart D., Murasko D. M., Brinton M. A. Varying role of α/β interferon in the antiviral efficacy of synthetic immunomodulators against Semliki Forest virus infection. Antiviral Res. 15:1991;241-254.
32. Muller U., Steinhoff U., Reis L. F. L., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. Functional role of type 1 and type 2 interferons in antiviral defense. Science. 264:1994;1918-1921.
33. Murray L., Martens C. Abnormal T cells from lpr mice down-regulate transcription of interferon-γ and tumor necrosis factor-αin vitro. Cell Immunol. 126:1990;367-376.
34. Pepose J. S., Hilborne L. H., Cancilla P. A., Foos R. Y. Concurrent HSV and CMV retinitis and encephalitis in the acquired immune deficiency syndrome (AIDS). Ophthalmology. 92:1984;1669-1677.
35. Pyo S., Gangemi J. D., Ghaffar A., Mayer E. P. Poly I:C-induced anti-herpes simplex type 1 activity in inflammatory macrophages is mediated by induction of interferon β J. Leukocyte Biol. 50:1991;479-487.
36. Quinnan G. V., Manischewitz J. F. Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication. J. Virol. 61:1987;1875-1881.
37. Schatz D. G., Selden R. F., Coen D. M. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Short Protocols in Molecular Biology. 1992;2-24-2-30 Wiley, New York.
38. Sen G. C., Ransohoff R. M. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42:1993;57-102.
39. Su Y., Oakes J. E., Lausch R. N. Ocular virulence of a HSV type 1 strain is associated with heightened sensitivity to α/β interferon. J. Virol. 64:1990;2187-2192.
40. Taylor J. L., O'Brien W. J. Interferon production in inbred mice during herpetic eye disease. Curr. Eye Res. 6:1987;259-264.
41. Wen R., Song Y., Cheng T., Matthes M. T., Yasumura D., LaVail M. M., Steinberg R. H. Injury-induced upregulation of bFGF and CNTF mRNAs in the rat retina. J. Neurosci. 15:1995;7377-7385.
42. Whittum J. A., McCulley J. P., Niederkorn J. Y., Streilein J. W. Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus. Invest. Ophthal. Vis. Sci. 25:1984;1065-1073.
43. Whittum-Hudson J. HSV-induced stimulation of retinal Müller cellsin vivo. Invest. Ophthalmol. Vis. Sci. 33:1992;786.
44. Whittum-Hudson J., Farazdaghi M., Prendergast R. A. A role for T lymphocytes in preventing experimental herpes simplex virus type 1-induced retinitis. Invest. Ophthal. Vis. Sci. 26:1985;1524-1532.
45. Whittum-Hudson J. A., Pepose J. S. Immunologic modulation of virus-induced pathology in a murine model of acute herpetic retinal necrosis. Invest. Ophthal. Vis. Sci. 28:1987;1541-1548.
46. Wynn T. A., Eltoum I., Cheever A. W., Lewis F. A., Gause W. C., Scher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs ofSchistosoma mansoni. J. Immunol. 151:1993;1430-1440.